Acadia Pharmaceuticals Files 8-K on Financials
Ticker: ACAD · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1070494
| Field | Detail |
|---|---|
| Company | Acadia Pharmaceuticals Inc (ACAD) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ACAD
TL;DR
ACADIA dropped an 8-K on Feb 26th detailing financial results. Check it out.
AI Summary
Acadia Pharmaceuticals Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This filing provides investors with crucial updates on Acadia Pharmaceuticals' financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not indicate any immediate or significant risks.
Key Players & Entities
- ACADIA PHARMACEUTICALS INC (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- San Diego, California (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on February 26, 2025.
What is the principal business address of Acadia Pharmaceuticals Inc.?
The principal executive offices are located at 12830 El Camino Real, Suite 400, San Diego, California, 92130.
What is the Commission File Number for Acadia Pharmaceuticals Inc.?
The Commission File Number is 000-50768.
Under which section of the Securities Exchange Act is this report filed?
This Current Report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding ACADIA PHARMACEUTICALS INC (ACAD).